Skip to content

Study to evaluate use of triphaladi churna orally and vidangadi churna massage in skin diseases.

Three Arm Comparative Clinical Study To Evaluate The Efficacy of Triphaladi Churna Orally, Vidangadi Udvartana Topically and Both combined together in Vicharchika with special reference to Eczema - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090273
Enrollment
60
Registered
2025-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Shreya Subhash Gunjal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group: - 18 to 60 years. 2.Patients with clinical features of Vicharchika having signs and symptoms namely Kandu(itching),Pidaka(Eruption),Vaivarnya(Depigmentation) and Srava (Discharge). 3. Patients of both Gender. 4. Understanding and being willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patient having severe systemic diseases or condition along with Vicharchika. 2. Pregnant & Lactating women. 3. Known case of Diabetes Mellitus. 4. Any other infective skin disorder

Design outcomes

Primary

MeasureTime frame
1. To study the efficacy of Vidangadi Udvartana topically using EASI score. 2. To study the efficacy of Triphaladi Churna orally using EASI score. 3. To study the combined efficacy of Triphaladi Churna (orally) and Vidangadi Udvartana (topically) in using EASI score. Timepoint: 12 Weeks

Secondary

MeasureTime frame
To compare the effect of Triphaladi Churna (orally) with Vidangadi Udvartana (topically) in signs and symptoms of Vicharchika . Timepoint: 12 Weeks

Countries

India

Contacts

Public ContactDr Shreya Subhash Gunjal

Arogyashala Rugnalaya Panchavati Nashik

sanjivanirathod431@gmail.com8007229141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026